Erdik N, Erdik A, Kizil D, Yavuzbilge G, Turk S, Guneysu C
BMC Urol. 2024; 24(1):257.
PMID: 39563281
PMC: 11577642.
DOI: 10.1186/s12894-024-01650-1.
Xu S, Wang B, Pang Q, Zhong L, Ding Y, Huang Y
Beijing Da Xue Xue Bao Yi Xue Ban. 2023; 55(4):676-683.
PMID: 37534651
PMC: 10398771.
Wanifuchi A, Kyoda Y, Ogasawara T, Kobayashi K, Ito N, Shindo T
Curr Urol. 2023; 17(3):174-178.
PMID: 37448620
PMC: 10337814.
DOI: 10.1097/CU9.0000000000000197.
Lee K, Park S, Choi P, Ryoo S, Lee H, Peri L
Sci Rep. 2021; 11(1):16268.
PMID: 34381120
PMC: 8357952.
DOI: 10.1038/s41598-021-95781-2.
Kwon S, Park D, Seo Y, Lee K
Investig Clin Urol. 2020; 61(4):419-424.
PMID: 32665999
PMC: 7329635.
DOI: 10.4111/icu.2020.61.4.419.
What are the origins and relevance of spontaneous bladder contractions? ICI-RS 2017.
Drake M, Fry C, Hashitani H, Kirschner-Hermanns R, Rahnamai M, Speich J
Neurourol Urodyn. 2018; 37(S4):S13-S19.
PMID: 29360173
PMC: 6056343.
DOI: 10.1002/nau.23485.
Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms.
Li J, Tian Y, Guo S, Gu H, Yuan Q, Xie X
PLoS One. 2018; 13(1):e0191469.
PMID: 29351556
PMC: 5774778.
DOI: 10.1371/journal.pone.0191469.
Pathophysiology of the underactive bladder.
Aizawa N, Igawa Y
Investig Clin Urol. 2017; 58(Suppl 2):S82-S89.
PMID: 29279880
PMC: 5740034.
DOI: 10.4111/icu.2017.58.S2.S82.
Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction.
Aizawa N, Ichihara K, Fukuhara H, Fujimura T, Andersson K, Homma Y
Sci Rep. 2017; 7(1):7646.
PMID: 28794457
PMC: 5550413.
DOI: 10.1038/s41598-017-07898-y.
Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment.
Kim A, Lee K, Kim T, Kim H, Yoo E, Yun J
Investig Clin Urol. 2017; 58(1):42-47.
PMID: 28097267
PMC: 5240281.
DOI: 10.4111/icu.2017.58.1.42.
The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivity.
Drake M, Kanai A, Bijos D, Ikeda Y, Zabbarova I, Vahabi B
BJU Int. 2016; 119(1):22-29.
PMID: 27444952
PMC: 5177525.
DOI: 10.1111/bju.13598.
Overactive bladder syndrome: Current pathophysiological concepts and therapeutic approaches.
Osman N, Chapple C
Arab J Urol. 2015; 11(4):313-8.
PMID: 26558098
PMC: 4443009.
DOI: 10.1016/j.aju.2013.07.006.
Imaging assessments of lower urinary tract dysfunctions: Future steps.
Farag F, Heesakkers J
Turk J Urol. 2015; 40(2):78-81.
PMID: 26328155
PMC: 4548377.
DOI: 10.5152/tud.2014.43650.
The innate immune response during urinary tract infection and pyelonephritis.
Spencer J, Schwaderer A, Becknell B, Watson J, Hains D
Pediatr Nephrol. 2013; 29(7):1139-49.
PMID: 23732397
PMC: 3800267.
DOI: 10.1007/s00467-013-2513-9.
Overactive bladder, differential diagnosis, and clinical utility of fesoterodine.
Wyndaele J
Int J Gen Med. 2012; 5:943-51.
PMID: 23204858
PMC: 3508565.
DOI: 10.2147/IJGM.S24236.
Loss of adenosine A2B receptor mediated relaxant responses in the aged female rat bladder; effects of dietary phytoestrogens.
Owen S, Massa H, RoseMeyer R
Naunyn Schmiedebergs Arch Pharmacol. 2012; 385(5):539-49.
PMID: 22237834
DOI: 10.1007/s00210-011-0722-y.
The overactive bladder.
Foon R, Drake M
Ther Adv Urol. 2011; 2(4):147-55.
PMID: 21789091
PMC: 3126078.
DOI: 10.1177/1756287210373757.
Management of overactive bladder.
Gulur D, Drake M
Nat Rev Urol. 2010; 7(10):572-82.
PMID: 20930868
DOI: 10.1038/nrurol.2010.147.
Autonomous nervous system activity in women with detrusor overactivity.
Im H, Kim M, Kim J, Choi J
Korean J Urol. 2010; 51(3):183-6.
PMID: 20414394
PMC: 2855458.
DOI: 10.4111/kju.2010.51.3.183.
Protective action of intravesical oxybutynin on bladder ultrastructure in rabbits with detrusor overactivity.
Yamamoto H, Kawano P, Balasteghin K, Padovani C, Amaro J
Int Urogynecol J Pelvic Floor Dysfunct. 2008; 20(2):229-34.
PMID: 18953475
DOI: 10.1007/s00192-008-0745-1.
